Investigation of Structure-Activity Relationships of Dexrazoxane Analogs Reveals Topoisomerase IIβInteraction as a Prerequisite for Effective Protection against Anthracycline Cardiotoxicity-Reference-Cited by-同舟云学术

Investigation of Structure-Activity Relationships of Dexrazoxane Analogs Reveals Topoisomerase IIβInteraction as a Prerequisite for Effective Protection against Anthracycline Cardiotoxicity

Published:2020-04-06 Issue:3 Volume:373 Page:402-415
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Kollárová-Brázdová Petra^ORCID,Jirkovská Anna^ORCID,Karabanovich Galina^ORCID,Pokorná Zuzana^ORCID,Bavlovič Piskáčková Hana^ORCID,Jirkovský Eduard^ORCID,Kubeš Jan^ORCID,Lenčová-Popelová Olga^ORCID,Mazurová Yvona^ORCID,Adamcová Michaela^ORCID,Skalická Veronika^ORCID,Štěrbová-Kovaříková Petra^ORCID,Roh Jaroslav^ORCID,Šimůnek Tomáš^ORCID,Štěrba Martin^ORCID

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference45 articles.

1. Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations

2. Cancer Therapy–Related Cardiac Dysfunction and Heart Failure

3. Investigation of novel dexrazoxane analogue JR-311 shows significant cardioprotective effects through topoisomerase IIbeta but not its iron chelating metabolite;Bures;Toxicology,2017

4. Creighton AM (1976) inventor, National Research Development Corporation, assignee. Bis diketopiperazines. Patent US3941790A. 1976 Mar 2.

5. Creighton AM (1992) inventor, National Research Development Corporation, assignee. Cardioprotective bis-dioxopiperazines. Patent GB2245832A. 1992 Jan 15.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches for reducing chemo/radiation-induced cardiotoxicity by nanoparticles;Environmental Research;2024-03

2. Exploring the effects of topoisomerase II inhibitor XK469 on anthracycline cardiotoxicity and DNA damage;Toxicological Sciences;2024-01-30

3. Prospects of Topoisomerase Inhibitors as Promising Anti-Cancer Agents;Pharmaceuticals;2023-10-13

4. An Overview on Cardio-Protective Compound Dexrazoxane;International Journal Of Health Care And Nursing;2023-07-27

5. MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response;Frontiers in Pharmacology;2022-11-21